Hematology

Deroxi liposomal® is indicated for the treatment of:

cancer of the breast in patients at risk for heart problems.

Cancer of the ovary.

In combination with another medicine, bortezomib, to treat multiple myeloma (a cancer of the blood) in patients who have received at least 1 prior therapy.

Produce an improvement in your Kaposi’s sarcoma.

Azacitidine SPC® is used in adults who are not able to have a stem cell transplantation to treat:

myelodysplastic syndromes (MDS).

acute myeloid leukaemia (AML)

Imatinib SPC® is indicated for the treatment of:

Philadelphia chromosome positive Chronic myeloid leukaemia (CML).

Philadelphia chromosome positive acute lymphoblastic leukaemia (Ph-positive ALL).

Gastro-intestinal Stromal Tumor (GIST)

Ensutine® is used for the treatment of the following forms of cancer:

• chronic lymphocytic leukaemia in cases where fludarabine combination chemotherapy is not appropriate for you
• non-Hodgkin’s lymphomas, which had not, or only shortly, responded to prior rituximab treatment
• multiple myeloma in cases where high-dose chemotherapy with autologous stem cell transplantation, thalidomide or bortezomib containing therapy is not appropriate for you.

CEKEA® is indicated for the treatment of:

Chronic myeloid leukaemia (CML)
Cervical cancer

Otrasa® is indicated for the treatment of adult & Paediatric patients with:

Chronic myelogenous leukaemia (CML)

Acute lymphoblastic leukaemia (ALL)